Core Viewpoint - Runhe Software's stock price increased by 2.07% on January 9, with a trading volume of 2.298 billion yuan, indicating positive market sentiment towards the company [1]. Financing Summary - On January 9, Runhe Software had a financing buy amount of 331 million yuan and a financing repayment of 304 million yuan, resulting in a net financing purchase of 27.43 million yuan [1]. - As of January 9, the total balance of margin trading for Runhe Software was 3.234 billion yuan, with the financing balance accounting for 7.73% of the circulating market value, which is below the 40th percentile level over the past year, indicating a relatively low financing level [1]. - In terms of securities lending, Runhe Software repaid 20,000 shares and sold 5,500 shares on January 9, with a selling amount of 287,800 yuan, while the remaining securities lending volume was 216,400 shares, with a balance of 11.3242 million yuan, also below the 10th percentile level over the past year [1]. Business Performance - As of September 30, Runhe Software had 233,500 shareholders, an increase of 1.43% from the previous period, with an average of 3,331 circulating shares per person, a decrease of 1.41% [2]. - For the period from January to September 2025, Runhe Software achieved an operating income of 2.719 billion yuan, representing a year-on-year growth of 12.86%, while the net profit attributable to the parent company was 78.5726 million yuan, a decrease of 29.01% year-on-year [2]. - Since its A-share listing, Runhe Software has distributed a total of 377 million yuan in dividends, with 55.2672 million yuan distributed over the past three years [2]. Institutional Holdings - As of September 30, 2025, the second-largest circulating shareholder of Runhe Software was E Fund's ChiNext ETF, holding 16.294 million shares, a decrease of 2.7319 million shares from the previous period [3]. - The third-largest circulating shareholder was Hua Bao's CSI Financial Technology Theme ETF, holding 13.0741 million shares, an increase of 634,630 shares [3]. - Other notable shareholders include Hong Kong Central Clearing Limited and Southern CSI 500 ETF, with varying changes in their holdings [3].

Core Viewpoint - Zhongke Jincai's stock price increased by 2.16% on January 9, with a trading volume of 831 million yuan, indicating a positive market sentiment despite a net financing outflow [1] Financing Summary - On January 9, Zhongke Jincai had a financing buy-in amount of 99.47 million yuan and a financing repayment of 105 million yuan, resulting in a net financing outflow of 5.97 million yuan [1] - The total financing and securities lending balance reached 719 million yuan, accounting for 7.23% of the circulating market value, which is above the 70th percentile level over the past year [1] - The company had a securities lending repayment of 0 shares and a securities lending sell-out of 16,000 shares, with a sell-out amount of 469,600 yuan, indicating a high securities lending balance of 716,100 yuan, exceeding the 80th percentile level over the past year [1] Business Performance Summary - As of September 30, Zhongke Jincai reported a total of 101,300 shareholders, an increase of 5.73% from the previous period, with an average of 3,306 circulating shares per person, a decrease of 5.79% [2] - For the period from January to September 2025, the company achieved an operating income of 544 million yuan, a year-on-year increase of 1.99%, while the net profit attributable to shareholders was -112 million yuan, a year-on-year decrease of 42.83% [2] - Since its A-share listing, Zhongke Jincai has distributed a total of 60.46 million yuan in dividends, with no dividends distributed in the past three years [2] Shareholder Structure Summary - As of September 30, 2025, the second-largest circulating shareholder is Huabao Zhongzheng Financial Technology Theme ETF, holding 5.58 million shares, an increase of 2.70 million shares from the previous period [2] - Hong Kong Central Clearing Limited is the third-largest circulating shareholder, holding 4.76 million shares, a decrease of 3.05 million shares from the previous period [2] - New shareholders include Guangfa Industry Select Three-Year Holding Period Mixed A and Bosera Financial Technology ETF, among others, indicating a shift in the shareholder base [2]

Core Insights - Jin Di Co., Ltd. experienced a stock price increase of 1.39% on January 9, with a trading volume of 174 million yuan [1] - The company reported a financing buy-in amount of 24.10 million yuan and a net financing buy of -128,600 yuan on the same day [1] - As of January 9, the total financing and securities lending balance for Jin Di Co., Ltd. was 157 million yuan, representing 8.25% of its circulating market value [1] Financing Summary - On January 9, Jin Di Co., Ltd. had a financing buy-in of 24.10 million yuan, with a current financing balance of 157 million yuan, which is above the 90th percentile level over the past year [1] - The company had a securities lending repayment of 300 shares on January 9, with no shares sold, resulting in a securities lending balance of 28.26 million yuan, also above the 90th percentile level over the past year [1] Business Performance - As of September 30, the number of shareholders for Jin Di Co., Ltd. was 21,000, a decrease of 17.76% from the previous period, while the average circulating shares per person increased by 21.59% to 3,365 shares [2] - For the period from January to September 2025, Jin Di Co., Ltd. achieved a revenue of 1.372 billion yuan, representing a year-on-year growth of 48.58%, and a net profit attributable to shareholders of 109 million yuan, up 30.06% year-on-year [2] - The company has distributed a total of 131 million yuan in dividends since its A-share listing [2] Shareholder Composition - As of September 30, 2025, Hong Kong Central Clearing Limited was the third-largest circulating shareholder with 1.4798 million shares, an increase of 990,500 shares from the previous period [2] - Guangfa Quantitative Multi-Factor Mixed A (005225) entered the top ten circulating shareholders as the fourth-largest with 827,200 shares [2] - Hai Futong Stock Mixed (519005) exited the list of the top ten circulating shareholders [2]

机构持仓方面，截止2025年9月30日，亚玛顿十大流通股东中，金元顺安元启灵活配置混合（004685） 退出十大流通股东之列。 责任编辑：小浪快报 资料显示，常州亚玛顿股份有限公司位于江苏省常州市天宁区青龙东路616号，成立日期2006年9月11 日，上市日期2011年10月13日，公司主营业务涉及光伏玻璃镀膜材料技术和工艺技术的研发,光伏玻璃 的镀膜生产以及光伏镀膜玻璃销售。主营业务收入构成为：太阳能玻璃85.54%，电子玻璃及其他玻璃 产品10.99%，电力销售2.27%，太阳能组件0.80%，其他0.40%。 截至9月30日，亚玛顿股东户数3.15万，较上期增加25.12%；人均流通股6308股，较上期减少20.08%。 2025年1月-9月，亚玛顿实现营业收入15.80亿元，同比减少35.42%；归母净利润-5957.04万元，同比减 少123.67%。 分红方面，亚玛顿A股上市后累计派现3.19亿元。近三年，累计派现2.32亿元。 1月9日，亚玛顿跌0.22%，成交额6499.33万元。两融数据显示，当日亚玛顿获融资买入额463.61万元， 融资偿还553.56万元，融资净买入-89.95万元。截至 ...

Group 1 - On January 9, Dongcheng Pharmaceutical's stock increased by 0.55%, with a trading volume of 162 million yuan. The financing buy amount was 13.51 million yuan, while the financing repayment was 15.99 million yuan, resulting in a net financing buy of -2.49 million yuan. The total financing and securities balance reached 1.13 billion yuan [1] - The financing balance of Dongcheng Pharmaceutical is 1.13 billion yuan, accounting for 9.47% of the circulating market value, which is above the 80th percentile level over the past year, indicating a high level [1] - On the same day, the company had a securities lending repayment of 300 shares and a securities lending sell of 9,500 shares, with a selling amount of 137,800 yuan. The remaining securities lending volume was 29,600 shares, with a balance of 429,200 yuan, which is below the 30th percentile level over the past year, indicating a low level [1] Group 2 - As of September 30, the number of shareholders of Dongcheng Pharmaceutical was 24,600, an increase of 4.51% compared to the previous period. The average circulating shares per person decreased by 4.32% to 30,191 shares [2] - For the period from January to September 2025, Dongcheng Pharmaceutical achieved an operating income of 2.04 billion yuan, a year-on-year decrease of 5.52%. The net profit attributable to the parent company was 149 million yuan, a year-on-year decrease of 10.64% [2] - Since its A-share listing, Dongcheng Pharmaceutical has distributed a total of 1 billion yuan in dividends, with 293 million yuan distributed in the last three years [3]

Core Viewpoint - Zhongji Xuchuang experienced a decline of 2.06% on January 9, with a trading volume of 22.201 billion yuan, indicating a significant market activity around the stock [1] Group 1: Financing and Margin Trading - On January 9, Zhongji Xuchuang had a financing buy-in amount of 3.517 billion yuan and a financing repayment of 2.976 billion yuan, resulting in a net financing buy of 541 million yuan [1] - As of January 9, the total margin trading balance for Zhongji Xuchuang was 21.525 billion yuan, with a financing balance of 21.470 billion yuan, accounting for 3.31% of the circulating market value, which is above the 90th percentile level over the past year [1] - In terms of securities lending, Zhongji Xuchuang had a repayment of 8,000 shares and a sell-out of 5,200 shares on January 9, with a sell-out amount of approximately 3.0326 million yuan, indicating a high level of activity in the lending market [1] Group 2: Company Performance and Shareholder Information - As of September 30, Zhongji Xuchuang reported a total revenue of 25.005 billion yuan for the first nine months of 2025, representing a year-on-year growth of 44.43%, and a net profit attributable to shareholders of 7.132 billion yuan, up 90.05% year-on-year [2] - The company has distributed a total of 1.943 billion yuan in dividends since its A-share listing, with 1.512 billion yuan distributed over the past three years [2] - As of September 30, 2025, the number of shareholders for Zhongji Xuchuang increased to 132,300, with an average of 8,353 circulating shares per person, a decrease of 3.02% from the previous period [2]

Group 1 - The core viewpoint of the news highlights the financial performance and trading activities of Jing Sheng Mechanical & Electrical Co., Ltd. on January 9, with a focus on its financing and margin trading status [1] - On January 9, Jing Sheng Mechanical's stock price fell by 0.77%, with a trading volume of 1.137 billion yuan. The net financing purchase was 15.84 million yuan, with a total financing and margin trading balance of 1.366 billion yuan [1] - The financing balance of Jing Sheng Mechanical accounted for 2.70% of its circulating market value, indicating a high level compared to the past year [1] Group 2 - As of September 30, the number of shareholders of Jing Sheng Mechanical increased by 25.88% to 86,800, while the average circulating shares per person decreased by 20.56% to 14,189 shares [2] - For the period from January to September 2025, Jing Sheng Mechanical reported a revenue of 8.273 billion yuan, a year-on-year decrease of 42.86%, and a net profit attributable to shareholders of 901 million yuan, down 69.56% year-on-year [2] - The company has distributed a total of 3.241 billion yuan in dividends since its A-share listing, with 2.027 billion yuan distributed in the last three years [2]

Core Viewpoint - Dongwu Securities experienced a mixed performance in trading activities, with a notable decrease in net financing buy and a significant increase in net profit year-on-year despite a drop in revenue [1][2]. Financing Activities - On January 9, Dongwu Securities recorded a financing buy of 51.33 million yuan, with a net financing buy of -36.35 million yuan, indicating a higher level of financing repayment than new purchases [1]. - The total financing and securities lending balance reached 3.134 billion yuan, with the financing balance accounting for 6.81% of the circulating market value, which is above the 70th percentile of the past year [1]. - In terms of securities lending, 115,700 shares were repaid, while 56,500 shares were sold, resulting in a selling amount of 522,100 yuan, with a remaining securities lending balance of 7.1739 million yuan, also above the 60th percentile of the past year [1]. Financial Performance - For the period from January to September 2025, Dongwu Securities reported an operating income of 7.274 billion yuan, a year-on-year decrease of 13.78%, while the net profit attributable to shareholders increased by 60.23% to 2.935 billion yuan [2]. - Cumulatively, since its A-share listing, Dongwu Securities has distributed a total of 8.684 billion yuan in dividends, with 3.955 billion yuan distributed over the past three years [3]. Shareholder Information - As of September 30, 2025, the number of shareholders increased by 24.26% to 111,100, while the average circulating shares per person decreased by 19.52% to 44,738 shares [2]. - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited holds 160 million shares, a decrease of 158 million shares compared to the previous period, while the Guotai CSI All-Index Securities Company ETF is a new sixth-largest shareholder with 103 million shares [3].

Group 1 - The core viewpoint of the news is that Minsheng Health has shown a mixed performance in terms of financing and stockholder metrics, with a notable increase in revenue and net profit year-on-year [1][2]. Group 2 - On January 9, Minsheng Health's stock price increased by 0.87%, with a trading volume of 132 million yuan. The financing buy-in amount was 14.12 million yuan, while the financing repayment was 15.40 million yuan, resulting in a net financing buy of -1.28 million yuan [1]. - As of January 9, the total balance of margin trading for Minsheng Health was 91.35 million yuan, with a financing balance of 91.08 million yuan, accounting for 5.08% of the circulating market value, which is below the 40th percentile level over the past year [1]. - The company has a high short-selling balance, with a short-selling volume of 16,400 shares and a short-selling balance of 266,200 yuan, exceeding the 90th percentile level over the past year [1]. - As of September 30, the number of shareholders for Minsheng Health was 19,700, a decrease of 8.51% from the previous period, while the average circulating shares per person increased by 7.98% to 5,547 shares [2]. - For the period from January to September 2025, Minsheng Health achieved an operating income of 623 million yuan, representing a year-on-year growth of 19.78%, and a net profit attributable to the parent company of 114 million yuan, up 32.77% year-on-year [2]. - Since its A-share listing, Minsheng Health has distributed a total of 71.20 million yuan in dividends [3]. - As of September 30, 2025, Hong Kong Central Clearing Limited was the fifth-largest circulating shareholder, holding 1.016 million shares, a decrease of 695,500 shares from the previous period [3].

Group 1 - The core viewpoint of the news is that FOSAI Technology has shown significant stock performance and financial growth, with a notable increase in both revenue and net profit in the recent reporting period [1][2]. Group 2 - On January 9, FOSAI Technology's stock rose by 8.56%, with a trading volume of 483 million yuan. The financing buy-in amount for the day was 61.65 million yuan, while the net financing buy-in was 16.31 million yuan, indicating strong investor interest [1]. - As of January 9, the total margin trading balance for FOSAI Technology was 385 million yuan, accounting for 5.49% of its market capitalization, which is above the 90th percentile level over the past year [1]. - FOSAI Technology's main business involves the research, production, and sales of automotive interior components, with revenue composition being 52.88% from functional parts, 42.16% from decorative parts, and 4.96% from others [1]. Group 3 - As of September 30, FOSAI Technology reported a total revenue of 1.268 billion yuan for the first nine months of 2025, representing a year-on-year growth of 34.81%. The net profit attributable to shareholders was 107 million yuan, showing a remarkable increase of 104.98% year-on-year [2]. - The number of shareholders for FOSAI Technology decreased by 14.61% to 7,243, while the average circulating shares per person increased by 17.11% to 6,245 shares [2]. - Notable institutional investors have entered FOSAI Technology's top ten circulating shareholders, including Yongying Advanced Manufacturing Mixed Fund and Xingquan Huan Yuan Mixed Fund, both of which are new shareholders [2].